PACS Group (PACS) Competitors $12.89 +0.09 (+0.70%) As of 12:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACS vs. GH, RDNT, BTSG, SHC, OPCH, WGS, HTFL, PRVA, VCYT, and SGRYShould you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Heartflow (HTFL), Privia Health Group (PRVA), Veracyte (VCYT), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. PACS Group vs. Its Competitors Guardant Health RadNet BrightSpring Health Services Sotera Health Option Care Health GeneDx Heartflow Privia Health Group Veracyte Surgery Partners Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, media sentiment, profitability, analyst recommendations, institutional ownership and valuation. Do institutionals & insiders hold more shares of GH or PACS? 92.6% of Guardant Health shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media refer more to GH or PACS? In the previous week, Guardant Health had 7 more articles in the media than PACS Group. MarketBeat recorded 10 mentions for Guardant Health and 3 mentions for PACS Group. Guardant Health's average media sentiment score of 0.65 beat PACS Group's score of 0.15 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, GH or PACS? Guardant Health has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500. Comparatively, PACS Group has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Is GH or PACS more profitable? PACS Group has a net margin of 0.00% compared to Guardant Health's net margin of -49.93%. Company Net Margins Return on Equity Return on Assets Guardant Health-49.93% N/A -28.95% PACS Group N/A N/A N/A Which has stronger earnings and valuation, GH or PACS? PACS Group has higher revenue and earnings than Guardant Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M10.93-$436.37M-$3.35-19.33PACS Group$3.11B0.63$112.87MN/AN/A Do analysts prefer GH or PACS? Guardant Health presently has a consensus price target of $65.86, suggesting a potential upside of 1.70%. PACS Group has a consensus price target of $26.25, suggesting a potential upside of 103.65%. Given PACS Group's higher probable upside, analysts plainly believe PACS Group is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 1 Sell rating(s) 0 Hold rating(s) 23 Buy rating(s) 0 Strong Buy rating(s) 2.92PACS Group 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 SummaryGuardant Health beats PACS Group on 8 of the 13 factors compared between the two stocks. Get PACS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACS vs. The Competition Export to ExcelMetricPACS GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.96B$8.23B$6.05B$21.91BDividend YieldN/A2.17%5.73%3.64%P/E RatioN/A75.4385.1630.11Price / Sales0.6333.93518.1066.87Price / CashN/A22.0937.5723.91Price / BookN/A6.9512.404.71Net Income$112.87M$247.60M$3.32B$1.01B7 Day Performance-1.07%-1.16%0.52%-0.40%1 Month Performance23.82%0.93%10.05%1.47%1 Year Performance-68.51%10.52%75.51%15.07% PACS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACSPACS Group2.6947 of 5 stars$12.89+0.7%$26.25+103.6%-68.0%$1.96B$3.11B0.0032,433GHGuardant Health3.5577 of 5 stars$63.38+0.9%$65.75+3.7%+193.2%$7.84B$739.02M-18.922,021RDNTRadNet3.1832 of 5 stars$78.29+0.8%$76.80-1.9%+4.5%$5.97B$1.83B-391.4311,021Positive NewsBTSGBrightSpring Health Services2.6674 of 5 stars$28.87+1.8%$29.13+0.9%+95.7%$5.02B$11.27B93.1335,000News CoverageAnalyst ForecastGap UpSHCSotera Health2.7912 of 5 stars$16.22+1.7%$17.20+6.0%+3.8%$4.53B$1.10B202.783,000News CoverageOPCHOption Care Health4.8613 of 5 stars$27.33-0.6%$35.11+28.5%-11.4%$4.46B$5.00B21.868,088Positive NewsWGSGeneDx2.4372 of 5 stars$120.19+1.6%$104.13-13.4%+104.4%$3.40B$305.45M2,403.801,200News CoverageHTFLHeartflowN/A$37.28-1.0%$36.60-1.8%N/A$3.14BN/A0.00699Positive NewsPRVAPrivia Health Group3.6101 of 5 stars$24.13+0.2%$28.58+18.5%+39.7%$2.96B$1.74B219.381,140VCYTVeracyte3.6953 of 5 stars$36.04+0.1%$40.90+13.5%+0.1%$2.83B$479.13M109.22790SGRYSurgery Partners3.1794 of 5 stars$20.39-3.6%$31.43+54.1%-34.1%$2.71B$3.24B-14.2615,000 Related Companies and Tools Related Companies GH Alternatives RDNT Alternatives BTSG Alternatives SHC Alternatives OPCH Alternatives WGS Alternatives HTFL Alternatives PRVA Alternatives VCYT Alternatives SGRY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PACS) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PACS Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PACS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
